COVID-19, Follow-up, Infectious Diseases, Respiratory
Conditions
Brief summary
This is a multi-centre population-based follow-up study for all 504 patients with laboratory-confirmed COVID-19. This study establishes a standardized and structured clinical database to provide complete and multidimensional clinical diagnosis and treatment data of novel coronavirus pneumonia, which also support future epidemiological, infectious disease study and patients' prognosis, by collecting clinical data and the related data of patients with novel coronavirus pneumonia in Southern Zhejiang province.
Detailed description
The follow-up information will be collected in one-month, three-month, six-month and one-year after discharge. Information about symptoms, radiographic and laboratory findings, lung function, SF-36 QUESTIONNAIRE, antibody of COVID19，result of RT-PCR Test and suvival information will be collected through all time frames.
Interventions
None listed
Sponsors
Wenzhou Medical University
First Affiliated Hospital of Wenzhou Medical University
Wenzhou Central Hospital And Sixth People's Hospital of Wenzhou Medical University
Yueqing Hospital of Wenzhou Medical University
Ruian Hospital of Wenzhou Medical University
Cangnan Hospital of Wenzhou Medical University
Pingyang Hospital of Wenzhou Medical University
Yongjia People's Hospital
Second Affiliated Hospital of Wenzhou Medical University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* All patients with laboratory-confirmed COVID-19 in Wenzhou
Exclusion criteria
* Suspected cases of COVID-19
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 36-Item Short Form Survey Instrument (SF-36) | one month, three month, six month and one year after discharge, minimum score | sum score of SF 36 form in each time frame |
| the value of FEV1 by lung function test | one month, three month, six month and one year after discharge | — |
| the ratio of FEV1 to FVC by lung function test | one month, three month, six month and one year after discharge | — |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Neutrophil value | one month, three month, six month and one year after discharge | laboratory result |
| DDI value | one month, three month, six month and one year after discharge | laboratory result |
| the proportion of applying ACEIs/ARBs medication | from the date of hospital admission to the day of hospital discharge | collect the number of applying ACEIs/ARBs medication and calculate the proportion |
| the predicted value of FEV1 by lung function test | one month, three month, six month and one year after discharge | — |
| number of cases returning to positive result in RT-PCR test | one month, three month, six month and one year after discharge | — |
| Number of positive outcome of IgG for antibody of COVID-19 | one month, three month, six month and one year after discharge | — |
| number of clinical symptoms after hospital discharge | one month, three month, six month and one year after discharge | clinical symptoms |
| the predicted ratio of FEV1 to FVC by lung function test | one month, three month, six month and one year after discharge | — |
| Lymphocyte value | one month, three month, six month and one year after discharge | laboratory result |
Countries
China
Outcome results
None listed